Related Experiment Video

Updated: May 13, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor

Keiichiro Iida1, Jun-Ichi Fukushi, Yoshihiro Matsumoto

  • 1Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Maidashi3-1-1, Fukuoka, 812-8582, Japan. fukushi@med.kyushu-u.ac.jp.

Cancer Cell International
|March 19, 2013
PubMed
Abstract

Insights

MicroRNA-125b (miR-125b) upregulation promotes chemoresistance in Ewing sarcoma (EWS) by inhibiting apoptosis. Targeting miR-125b could re-sensitize EWS cells to chemotherapy drugs like doxorubicin.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) regulate diverse cellular functions, including apoptosis and tumorigenesis.
  • Understanding miRNA roles in chemoresistance is crucial for developing effective cancer therapies.
  • Ewing sarcoma (EWS) is a challenging bone and soft tissue cancer where chemoresistance is a significant clinical problem.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in the development of chemoresistance in Ewing sarcoma (EWS).
  • To identify specific miRNAs that may regulate drug resistance in EWS cells.
  • To explore the therapeutic potential of targeting miRNAs in EWS.

Main Methods:

  • Screening of doxorubicin (Dox)-resistant EWS cells to identify differentially expressed miRNAs.
  • Chemosensitivity assays to evaluate the functional impact of identified miRNAs on drug response.
  • Bioinformatic prediction of miRNA target genes to elucidate underlying mechanisms.

Main Results:

  • miR-125b was found to be significantly upregulated in doxorubicin-resistant EWS cell lines and patient tumors.
  • Knockdown of miR-125b in EWS cells enhanced sensitivity to doxorubicin, accompanied by increased p53 and Bak expression.
  • Overexpression of miR-125b conferred resistance to multiple chemotherapeutic agents, including doxorubicin, etoposide, and vincristine.

Conclusions:

  • miR-125b plays a critical role in mediating chemoresistance in Ewing sarcoma.
  • This miRNA contributes to drug resistance by suppressing the expression of pro-apoptotic molecules like p53 and Bak.
  • Targeting miR-125b represents a potential strategy to overcome chemoresistance in EWS.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...